Evidence map›Paper›PMID 39534546›Full record

ArticleCureus2024

Early Diagnosis of Primary Right Atrial Angiosarcoma From Intraoperative Transesophageal Echocardiographic Findings of Right Atrial Pseudoaneurysm and Cardiac Rupture.

Masaru Shimizu, Taiken Banno, Misayo Nishikawa

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Masaru ShimizuAnesthesiology, Uji Tokushukai Medical Center, Uji, JPN.
Taiken BannoAnesthesiology, Uji Tokushukai Medical Center, Uji, JPN.
Misayo NishikawaAnesthesiology, Uji Tokushukai Medical Center, Uji, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary cardiac angiosarcoma is a rare and aggressive malignant tumor with a poor clinical outcome. Its nonspecific symptoms often complicate early diagnosis. Here, we present the case of a 39-year-old man who initially presented with pericardial effusion and cardiac tamponade. Despite multiple transthoracic echocardiography (TTE) and computed tomography (CT) scans from admission to surgery, no cardiac tumor was detected. After admission, pericardial drainage was performed following the parasternal approach. On day 5 after admission, TTE and chest CT revealed increased pericardial effusion compared to post-drainage on admission. On day 6 of admission, the patient underwent a left pericardial window creation under general anesthesia. We did not suspect malignancy until an intraoperative transesophageal echocardiography (TEE) was performed, which revealed a right atrial pseudoaneurysm despite subsequent negative imaging results. On day 7 of admission, the patient was treated with surgical resection of the pseudoaneurysm and repair of the right atrial wall, followed by a histopathologic diagnosis of cardiac angiosarcoma. The patient recovered without major complications, was discharged from the hospital, and is doing well. Early surgical intervention, as evidenced in this case, can substantially improve patient outcome. This report provides valuable insights into the management of cardiovascular angiosarcoma. We emphasize the importance of a multifaceted, comprehensive diagnostic evaluation that includes the use of advanced imaging modalities, such as TEE, to make a timely and accurate diagnosis, even in the absence of obvious tumor findings.

Indexed as

cardiac angiosarcomacardiac malignancypericardial effusionpericardiotomypseudoaneurysmtransesophageal echocardiography

Identifiers

PMID39534546
PMCPMC11556781

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.